Bone Bank Allografts Announces Partnership with Yankee Alliance
Agreement provides 15,000 members access to high-quality Orthobiologics
San Antonio, TX, December 9, 2019 (GLOBE NEWSWIRE) – Bone Bank Allografts (BBA), a leading provider of regenerative medicine technologies to the surgical community, announced a multi-year partnership agreement with Yankee Alliance, a group purchasing organization (GPO) with more than 15,000 members across the United States. The agreement covers BBA’s comprehensive portfolio of orthobiologics that include surgical allograft options from traditional bone and soft tissues to specialty custom products for transplant.
“We are excited about our new long-term partnership with Yankee Alliance as their members now have greater access to high-quality solutions that address hospital and surgeon needs at a lower total cost of care today as well as moving forward,” said Chris Gould, Senior Director of National Accounts at BBA.
“Yankee Alliance has chosen to partner with BBA in order to give our Members access to high-quality allograft products from a leading provider of regenerative medicine technologies to the surgical community at a very competitive price point,” said Leigh Lambert, Senior Manager, Contracting & Legal Affairs at Yankee Alliance. “We look forward to working with BBA to provide savings and quality products to our Membership.”
Distributors and independent sales agents who are looking for the opportunity to sell orthobiologics to hospitals and surgeons are encouraged to request a meeting with BBA leadership by visiting bonebank.com.
About Bone Bank Allografts (BBA)
Located in San Antonio, Texas BBA is leading provider of regenerative medicine technologies to the surgical community. Utilized in over 1 million successful transplantations since 1993, BBA is dedicated to maximizing the gift of donations by developing solutions that promote healing and recovery. BBA is accredited by the American Association of Tissue Banks (AATB), registered with the U.S. Food and Drug Administration (FDA) and in compliance with the FDA’s Good Tissue Practices. Visit bonebank.com to learn more.
About Yankee Alliance
Yankee Alliance, an owner of Premier Inc., is a group purchasing organization founded in 1984 on a belief in collaboration, that working together can achieve more than working alone. Its mission is twofold: to work with members to reduce supply and operating expenses through aggregation of data, purchasing, ideas and knowledge and to excel in strategic innovations that continually assist members in reducing their cost while recognizing their individual needs. Today, Yankee Alliance remains true to the foundational belief in collaboration and has grown to over 15,000 members in all classes of trades across all 50 states. WWW.YANKEEALLIANCE.COM .
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with changing laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Sr. Director of National Accounts